Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
The American Journal of Medicine|August 20, 2013
Breaking down patient and physician barriers to optimize glycemic control in type 2 diabetesStuart A RossCurrent Medical Research and Opinion|October 10, 2014
A multiplicity of targets: evaluating composite endpoint studies of the GLP-1 receptor agonists in type 2 diabetesStuart A RossDiabetes Research and Clinical Practice|August 19, 2004
Controlling diabetes: the need for intensive therapy and barriers in clinical managementStuart A RossCurrent Medical Research and Opinion|August 27, 2013
Early use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in type 2 diabetesStuart A Ross, Jane BallantineCanadian Family Physician Medecin De Famille Canadien|July 16, 2010
Incretin agents in type 2 diabetesStuart A Ross, Jean-Marie EkoéCurrent Medical Research and Opinion|September 28, 2011
Barriers to effective insulin treatment: the persistence of poor glycemic control in type 2 diabetesStuart A Ross, Hugh D Tildesley, John AshkenasDiabetes Care|July 30, 2010
Effect of Internet therapeutic intervention on A1C levels in patients with type 2 diabetes treated with insulinHugh D Tildesley, Adel B Mazanderani, Stuart A RossThe Medical Clinics of North America|December 3, 2014
Internet blood glucose monitoring systems provide lasting glycemic benefit in type 1 and 2 diabetes: a systematic reviewHugh D Tildesley, Michelle D Po, Stuart A RossExperimental Diabetes Research|March 5, 2008
Diabetic retinopathy in native and nonnative CanadiansStuart A Ross, Anne McKenna, Sheila Mozejko, et al.Neuroscience Letters|January 22, 2008
Protective properties afforded by pioglitazone against intrastriatal LPS in Sprague-Dawley ratsRandy L Hunter, Dong-Young Choi, Stuart A Ross, et al.Pageof 4